1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcomes of cutaneous adverse events to immune checkpoint inhibitors
    Meeting Abstract

    Wu, J.; Freites-Martinez, A.; Hellmann, M. D.; Rosenberg, J. E.; Motzer, R. J.; Chapman, P. B.; Rizvi, N. A.; Geskin, L. J.; Reed, V. A.; Dusza, S. W.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)
    Meeting Abstract

    Watts, J. M.; Baer, M. R.; Lee, S.; Yang, J.; Dinner, S. N.; Prebet, T.; Schiller, G. J.; Seiter, K.; Ferrell, P. B.; Kelly, P. F.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance)
    Meeting Abstract

    Wei, A. C. C.; Ou, F. S.; Shi, Q.; O'Reilly, E. M.; Meyerhardt, J. A.; Wolff, R. A.; Kindler, H. L.; Evans, D. B.; Deshpande, V.; Misdraji, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • First-line PD-1/PD-L1 inhibitor followed by carboplatin (carbo)-based chemotherapy (chemo) or the reverse sequence in cisplatin-ineligible metastatic urothelial cancer (mUC) patients (pts)
    Meeting Abstract

    Wei, X. X.; Lundgren, K.; Teo, M. Y.; Rosenberg, J. E.; Koshkin, V. S.; Grivas, P.; Carril, L.; Castellano, D. E.; Velho, P.; Hahn, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Utilization of telemedicine at two high-volume cancer care organizations
    Meeting Abstract

    Williams, R.; Aspden, M.; Stetson, P. D.; Otto, C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Mutational analysis and safety/efficacy in a phase 2 multi-center investigation of ABI-009 (nab-rapamycin) in patients with advanced malignant perivascular epithelioid cell tumors (PEComa)
    Meeting Abstract

    Wagner, A. J.; Riedel, R. F.; Van Tine, B. A.; Chugh, R.; Ganjoo, K. N.; Cranmer, L. D.; Pollack, S.; Sankhala, K. K.; Gordon, E. M.; Ravi, V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Association of sex and adverse events (AEs) of adjuvant chemotherapy (ACT) in early stage colon cancer (CC): A pooled analysis of 28,636 patients (pts) in the ACCENT database
    Meeting Abstract

    Wagner, A. D.; Grothey, A.; Andre, T.; Dixon, J.; Wolmark, N.; Haller, D. G.; Allegra, C. J.; VanCutsem, E.; George, T. J.; De Gramont, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Longer follow-up on clinical outcomes of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2 overexpressing metastatic breast cancer
    Meeting Abstract

    Wang, R.; Smyth, L. M.; Iyengar, N. M.; Modi, S.; Chandarlapaty, S.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Insurance disparity and outcomes among younger non-small cell lung cancer (NSCLC) patients: A SEER analysis 2007-2014
    Meeting Abstract

    Wang, Q.; Jiang, C.; Zhang, Y.; Kunte, S.; Deng, L.; Liu, Y.; Xiao, Z.; Perimbeti, S.; Daly, R. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save